4-Chloro-6-iodoquinazoline: Your Key to Advanced Pharmaceutical Synthesis
Unlock the potential of Lapatinib and other vital therapeutics with this critical pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
4-Chloro-6-iodoquinazoline
4-Chloro-6-iodoquinazoline (CAS 98556-31-1) stands as a cornerstone intermediate in the complex chemical synthesis of Lapatinib, a vital targeted therapy for certain types of cancer. Its specific molecular structure, featuring both a chlorine and an iodine atom on a quinazoline core, makes it indispensable for building the complex framework of Lapatinib, thereby contributing significantly to advancements in oncology treatments. This compound is essential for pharmaceutical companies and research institutions focused on developing and manufacturing innovative cancer drugs.
- Explore the critical role of 4-Chloro-6-iodoquinazoline in Lapatinib production, a key advancement in cancer treatment.
- Discover the detailed Lapatinib synthesis pathway and how this intermediate facilitates efficient drug development.
- Learn about the applications of quinazoline derivatives like 4-Chloro-6-iodoquinazoline in modern pharmaceutical research.
- Understand the importance of this CAS 98556-31-1 in creating advanced chemical intermediates for oncology applications.
Key Advantages
Enhanced Synthesis Efficiency
Leveraging 4-Chloro-6-iodoquinazoline in your synthesis process for Lapatinib ensures a streamlined and efficient pathway, reducing development time and costs for critical oncology drugs.
High Purity and Reliability
Sourced with stringent quality controls, this intermediate guarantees the purity and consistency required for pharmaceutical applications, meeting the exacting standards of drug manufacturing.
Foundation for Novel Therapeutics
As a versatile quinazoline derivative, 4-Chloro-6-iodoquinazoline serves as a building block for not only Lapatinib but also for the exploration and synthesis of other novel cancer therapeutics.
Key Applications
Pharmaceutical Synthesis
The primary application of 4-Chloro-6-iodoquinazoline is as a crucial building block in the multi-step synthesis of Lapatinib, an important anti-cancer medication. Its chemical structure is specifically designed to enable subsequent reactions that form the final drug molecule.
Oncology Drug Development
This compound is integral to research and development efforts focused on new anti-cancer agents. Its quinazoline core is a common scaffold in kinase inhibitors, making it valuable for exploring new therapeutic targets in cancer treatment.
Chemical Research
Researchers utilize 4-Chloro-6-iodoquinazoline in academic and industrial settings for exploring novel chemical reactions, developing new synthetic methodologies, and investigating the properties of quinazoline derivatives.
Intermediates for API Manufacturing
As a key intermediate, it plays a direct role in the manufacturing of Active Pharmaceutical Ingredients (APIs), ensuring a reliable supply chain for life-saving medications like Lapatinib.